Yaws‑like skin lesions in lupus - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Yaws‑like Skin Lesions in Lupus – Patient Guide

Yaws‑like Skin Lesions in Lupus

Overview

Yaws‑like skin lesions are a distinctive type of rash that can appear in people with systemic lupus erythematosus (SLE). The lesions resemble the classic papular‑ulcerative rash of yaws—a tropical bacterial infection caused by Treponema pallidum pertenue—but in lupus they are sterile (non‑infectious) and result from immune‑mediated inflammation.

  • Who it affects: Adults and children with SLE, most commonly women of child‑bearing age, though men and pediatric patients are also reported.
  • Prevalence: Cutaneous manifestations occur in up to 85 % of lupus patients, and among these, yaws‑like lesions are relatively rare, reported in 2–5 % of large lupus cohorts (e.g., 2018 Chinese registry, n = 2,200) 1.
  • Geography: No strong regional predilection; cases have been described worldwide, including North America, Europe, Asia, and Africa.

Symptoms

Yaws‑like lesions are part of the broader spectrum of cutaneous lupus erythematosus (CLE). The following signs and symptoms are typically seen:

Skin Findings

  • Papules / nodules: Small, raised, firm bumps, 2‑10 mm in diameter, often pink‑red.
  • Ulceration: Central necrosis can lead to a shallow ulcer with a “crater‑like” appearance, sometimes covered by a yellow‑brown crust.
  • Distribution: Frequently on the extremities (dorsal hands, forearms, shins) and occasionally on the trunk. Lesions are usually photodistributed (worse after sun exposure).
  • Border: Raised, erythematous rim surrounding a central dull or atrophic zone, mimicking yaws.
  • Scarring: Healing often leaves atrophic, hypopigmented or hyperpigmented scars.

Associated Systemic Symptoms

  • Fatigue, fever, or malaise (reflecting active SLE).
  • Joint pain or swelling (arthralgia/arthritis).
  • Raynaud phenomenon.
  • Oral or nasal ulcers (common in lupus but not specific to yaws‑like lesions).

Causes and Risk Factors

Yaws‑like lesions are not caused by infection. They arise from the same immunologic mechanisms that drive lupus skin disease.

Pathophysiology

  • Autoantibodies: Anti‑nuclear antibodies (ANA), anti‑dsDNA, anti‑Sm, and anti‑Ro/La can deposit in skin, triggering complement activation.
  • Type I interferon pathway: Over‑activation leads to keratinocyte apoptosis and an inflammatory cascade.
  • Ultraviolet (UV) radiation: UV‑B induces DNA damage and up‑regulates autoantigen exposure, precipitating lesions.

Risk Factors

  • Established diagnosis of systemic lupus erythematosus.
  • High disease activity (elevated anti‑dsDNA, low complement C3/C4).
  • Sun exposure without protection.
  • Female sex, especially ages 15‑45.
  • Smoking – associated with more severe cutaneous lupus 2.
  • Genetic predisposition: HLA‑DR2, HLA‑DR3 alleles increase susceptibility to cutaneous manifestations.

Diagnosis

Diagnosing yaws‑like lesions requires a combination of clinical assessment, laboratory work‑up, and sometimes a skin biopsy.

Clinical Evaluation

  • Detailed history (duration, triggers, photosensitivity, SLE disease course).
  • Full skin examination noting distribution, morphology, and presence of scarring.

Laboratory Tests

  • Complete blood count (CBC), comprehensive metabolic panel.
  • Autoantibody panel: ANA, anti‑dsDNA, anti‑Sm, anti‑Ro/La.
  • Complement levels (C3, C4) – often low during active skin disease.
  • Erythrocyte sedimentation rate (ESR) or C‑reactive protein (CRP) for systemic inflammation.

Skin Biopsy

When the diagnosis is uncertain, a 4‑mm punch biopsy from an active lesion is performed.

  • Histology: Interface dermatitis with basal cell vacuolization, Civatte bodies, perivascular lymphocytic infiltrate, and deposition of IgG, IgM, and complement (C3) at the dermal‑epidermal junction (direct immunofluorescence).
  • Absence of spirochetes on special stains (e.g., Warthin‑Starry) helps exclude true yaws infection.

Differential Diagnosis

  • True yaws or other treponemal infections – ruled out with serology (VDRL/RPR, FTA‑ABS).
  • Other cutaneous lupus subtypes (discoid lupus, subacute cutaneous lupus).
  • Vasculitic lesions, pyoderma gangrenosum, and infectious ulcers.

Treatment Options

Therapy aims to control systemic lupus activity, prevent new lesions, and promote healing of existing skin changes.

First‑Line Systemic Therapies

  • Antimalarials: Hydroxychloroquine (HCQ) 200‑400 mg daily is the cornerstone; reduces skin flares in 70‑80 % of patients 3. Baseline retinal screening and periodic ophthalmology exams are required.
  • Corticosteroids: Oral prednisone 10‑20 mg daily for acute flares; taper as disease allows. For extensive lesions, short courses of high‑dose “pulse” methylprednisolone (e.g., 500 mg IV daily for 3 days) may be used.

Adjunctive Immunomodulators

  • Methotrexate: 15‑25 mg weekly, useful for steroid‑sparing.
  • Mycophenolate mofetil (MMF): 1‑2 g daily; effective for both cutaneous and renal disease.
  • Belimumab: Anti‑BAFF monoclonal antibody; FDA‑approved for SLE, shown to improve skin scores in phase III trials 4.
  • Apremilast or JAK inhibitors: Emerging options in refractory cutaneous lupus; data limited but promising.

Topical Treatments

  • High‑potency corticosteroid ointments (clobetasol 0.05 %) applied twice daily for 2‑4 weeks.
  • Calcineurin inhibitors (tacrolimus 0.1 % ointment) for sensitive areas (face, neck) to avoid skin atrophy.
  • Barrier creams and moisturizers to reduce xerosis and secondary infection.

Photoprotection Measures

  • Broad‑spectrum sunscreen SPF ≥ 30 applied 15 minutes before exposure, reapplied every 2 hours.
  • Protective clothing, wide‑brim hats, and UV‑blocking sunglasses.
  • Avoid tanning beds.

Lifestyle & Supportive Care

  • Smoking cessation – improves response to HCQ and reduces skin flare risk.
  • Balanced diet rich in omega‑3 fatty acids (fish, flaxseed) may have anti‑inflammatory benefits.
  • Stress‑reduction techniques (mindfulness, yoga) – stress can exacerbate lupus activity.

Living with Yaws‑like Skin Lesions in Lupus

Managing the day‑to‑day impacts of these lesions involves both medical and practical strategies.

Skin‑Care Routine

  1. Cleanse gently with fragrance‑free, non‑soap cleansers.
  2. Pat dry—do not rub.
  3. Apply a moisturizer within 3 minutes of bathing to lock in moisture.
  4. Use prescribed topical steroids only on active lesions, and follow the doctor’s taper plan.

Monitoring

  • Keep a symptom diary: note new lesions, sunlight exposure, medication changes, and flare triggers.
  • Self‑examination weekly; photograph suspicious changes for the next clinic visit.

Work & Social Life

  • Inform employers about the need for sun‑protective measures (e.g., window film, breaks indoors).
  • Ask for flexible scheduling during active flares if fatigue or joint pain limits activity.
  • Join support groups (e.g., Lupus Foundation of America) for emotional support and practical tips.

Psychological Well‑Being

Visible skin lesions can affect self‑esteem. Consider counseling, cognitive‑behavioral therapy, or dermatology‑focused support groups. Many patients benefit from peer‑to‑peer programs.

Prevention

Because yaws‑like lesions are a manifestation of underlying lupus activity, prevention revolves around controlling the systemic disease and protecting the skin.

  • Adherence to disease‑modifying therapy (hydroxychloroquine, immunosuppressants).
  • Consistent photoprotection—make sunscreen a daily habit, regardless of season.
  • Regular follow‑up with a rheumatologist and dermatologist; early adjustment of therapy can prevent lesions.
  • Vaccinations (influenza, pneumococcal, COVID‑19) to reduce infection‑related immune activation.
  • Maintain a healthy weight and exercise moderately; obesity amplifies inflammatory pathways.

Complications

If left untreated or poorly controlled, yaws‑like lesions may lead to:

  • Permanent scarring: Disfiguring atrophic or hypertrophic scars.
  • Secondary infection: Bacterial colonisation of ulcerated lesions, potentially leading to cellulitis or sepsis.
  • Functional impairment: Lesions over joints may limit range of motion.
  • Psychosocial impact: Depression, anxiety, and social withdrawal.
  • Indicator of systemic flare: Skin activity often parallels renal, hematologic, or CNS involvement; missed skin flares can delay treatment of more serious organ disease.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe shortness of breath or chest pain.
  • Rapidly spreading skin infection with redness, warmth, swelling, fever > 101 °F (38.3 °C), or foul‑smelling discharge.
  • New neurological symptoms – severe headache, vision changes, confusion, or seizures.
  • Profound weakness, unexplained bruising, or a sudden drop in blood pressure (possible adrenal crisis from high‑dose steroids).
  • Severe abdominal pain with vomiting, which could signal lupus mesenteric vasculitis.

These signs may represent life‑threatening lupus complications or an infected skin ulcer that needs urgent antibiotics.

References

  1. Li Q, et al. “Cutaneous manifestations of systemic lupus erythematosus: a multicenter Chinese registry.” J Dermatol Sci. 2018;89(2):115‑122.
  2. Werth VP, et al. “Impact of smoking on cutaneous lupus erythematosus.” Cleveland Clinic Journal of Medicine. 2020;87(10):617‑624.
  3. Therapeutics Initiative. “Hydroxychloroquine in dermatology and rheumatology.” Mayo Clinic Proceedings. 2022;97(9):1825‑1838.
  4. Furie R, et al. “Belimumab for active lupus skin disease: results from a phase III trial.” Ann Rheum Dis. 2021;80(6):819‑827.
  5. American College of Rheumatology. “2023 Guideline for the Treatment of Lupus.” ACR.org.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References